Literature DB >> 21188770

Prostate cancer: Contemporary aDt usage reflects established benefit.

Sarah Payton.   

Abstract

Entities:  

Year:  2010        PMID： 21188770     DOI： 10.1038/nrurol.2010.194

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Reimbursement policy and androgen-deprivation therapy for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-Fang Kuo; Scott M Gilbert
Journal:  N Engl J Med       Date:  2010-11-04       Impact factor: 91.245

2.  External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

Authors:  Michel Bolla; Geertjan Van Tienhoven; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Ignace Billiet; José Lopez Torecilla; Raphael Pfeffer; Carmel Lino Cutajar; Theodore Van der Kwast; Laurence Collette
Journal:  Lancet Oncol       Date:  2010-10-07       Impact factor: 41.316
  2 in total
  1 in total

1.  Regulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less.

Authors:  Bo Li; Wenfu Lu; Zhenbang Chen
Journal:  Receptors Clin Investig       Date:  2014
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.